Empagliflozin Tablets 10 mg, 25 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg, 25 mg
Reference Brands: Jardiance(EU & US), Glyxet (India)
Category: Diabetes
Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in kidneys, promoting urinary glucose excretion. This lowers blood sugar in type 2 diabetes. Benefits include improved glycemic control, weight loss, blood pressure reduction, and cardiovascular risk reduction, with a low risk of hypoglycemia.
Product Description:
Empagliflozin is a selective SGLT2 inhibitor approved for managing type 2 diabetes mellitus, heart failure, and chronic kidney disease. In the USA, the FDA approved Jardiance (10 mg, 25 mg) in 2014. In the EU, it is authorized by the EMA under centralized procedure. It is often prescribed as monotherapy or in combination with metformin or insulin. Empagliflozin improves glycemic control and reduces cardiovascular risks. Regular renal monitoring is advised. Pharmatradz.com connects global buyers and suppliers with licensed manufacturers of Empagliflozin, ensuring regulatory-compliant sourcing for B2B needs in both regulated and semi-regulated markets.
Empagliflozin Tablets — third party manufacturing & bulk supply
Empagliflozin Tablets 10 mg, 25 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Empagliflozin Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Empagliflozin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Empagliflozin Tablets →Frequently Asked Questions
Empagliflozin is used to manage Type 2 diabetes mellitus. It helps lower blood sugar levels, reduce cardiovascular risk in patients with diabetes and heart disease, and support weight reduction.
Empagliflozin is a synthetic small-molecule drug and an SGLT2 (sodium-glucose co-transporter 2) inhibitor, which blocks glucose reabsorption in the kidneys, promoting its excretion through urine.
The main trade name is Jardiance.
Empagliflozin is manufactured by Boehringer Ingelheim in collaboration with Eli Lilly.
The generic name is Empagliflozin.
The brand name is Jardiance.
Empagliflozin is manufactured in Europe and the USA and distributed globally, including the USA, EU, India, and Japan.
Related Products
Dapagliflozin 10 Mg Tablets
Strength:
10 mg
Form: Tablets
Reference Brands: Forxiga(US & EU), Edistride (India), Dapazin (EU)
View DetailsCanagliflozin Tablets
Strength:
100 mg and 300 mg
Form: Tablets
Reference Brands: Invokana(US & EU)
View DetailsTeneligliptin Tablets
Strength:
20 mg, 40mg
Form: Tablets
Reference Brands: Tenelia®, Teneza®, and Teneliget®(India & Japan/ Asia)
View DetailsLiraglutide Subcutaneous Injection
Strength:
6 mg/mL solution
Form: Subcutaneous injection/Pre filled Pen
Reference Brands: Victoza(US & EU)
View DetailsInsulin Glulisine
Strength:
100 IU/mL
Form: injection (prefilled syringe)
Reference Brands: Apidra (USA/EU)
View DetailsAlogliptin Tablet
Strength:
6.25 mg, 12.5 mg, 25 mg
Form: Tablet
Reference Brands: Nesina (USA/EU), Kazano (USA), Vipidia (EU)
View DetailsNph Human Insulin (Rdna Origin)
Strength:
40U/ml, 100U/ml
Form: Injection
Reference Brands: Humulin (USA), Novolin (USA), Actrapid (EU/UK)
View DetailsQuick Response Guaranteed | Verified Suppliers